- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2202
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
In vivo diagnosis and therapy of Alzheimer's disease ; volume:8 ; number:1 ; day:23 ; month:3 ; year:2007 ; pages:1 ; date:3.2007
BMC neuroscience ; 8, Heft 1 (23.3.2007), 1, 3.2007
- Creator
-
Wiesehan, Katja
- Contributor
- DOI
-
10.1186/1471-2202-8-S1-P19
- URN
-
urn:nbn:de:1111-2016032054103
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wiesehan, Katja
- van Groen, Thomas
- Linke, Reinhold P.
- Patt, Stephan
- Willbold, Dieter
- SpringerLink (Online service)
Other Objects (12)
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Engineering and characterization of a binder to inhibit in vivo α-synuclein aggregation
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Engineering and characterization of a binder to inhibit in vivo α-synuclein aggregation
The modulating effect of soluble amyloid-β dimers on amyloid-β aggregation in vivo and in vitro
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Engineering and characterization of a binder to inhibit in vivo α-synuclein aggregation